Organoid-on-chip technology merges patient-derived organoids with microfluidic engineering to recreate human physiology and ...
This research presents nanogels that effectively target P. aeruginosa, achieving 99.9 % inhibition and opening a path to ...
The assay is currently offered for research use only and will be featured in demonstrations at ASH on Dec. 6-9, 2025, at Booth #2129, where Mission Bio will highlight use cases spanning therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback